PARLIAMENTARY WRITTEN QUESTION
(6 January 2025)
Question Asked
Asked by:
James McMurdock (Independent)
Answer
Each COVID-19 vaccine candidate is assessed by teams of scientists and clinicians on a case-by-case basis, and only authorised once it has met robust standards of effectiveness, safety, and quality set by the United Kingdom’s independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
No medicine or vaccine is completely risk-free, but the MHRA continually monitors the safety of the COVID-19 vaccines through its comprehensive COVID-19 vaccine surveillance strategy to ensure that the benefits of the COVID-19 vaccines continue to outweigh the risks. Should any information indicate a possible new safety concern, the system will rapidly and thoroughly investigate, with advice for healthcare professionals and patients updated where appropriate.
Answered by:
()
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.